Skip to Content

Tiotropium use while Breastfeeding

Drugs containing Tiotropium: Spiriva, Stiolto Respimat, Spiriva Respimat

Medically reviewed by Drugs.com. Last updated on April 6, 2021.

Tiotropium Levels and Effects while Breastfeeding

Summary of Use during Lactation

Although no published data exist on the use of tiotropium, its use produces negligible maternal serum levels and any drug in breastmilk would not be absorbed by the infant. The risk to the breastfed infant of maternal tiotropium inhalation is small.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Aclidinium, Umeclidinium

Substance Identification

Substance Name

Tiotropium

CAS Registry Number

136310-93-5

Drug Class

  • Breast Feeding
  • Lactation
  • Anti-Asthmatic Agents
  • Bronchodilator Agents
  • Muscarinic Antagonists
  • Parasympatholytics

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.